These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 23422360)

  • 1. Difference in clinical target lesion revascularization between a silicon carbide-coated and an uncoated thin strut bare-metal stent: the PRO-Vision study.
    Haine SE; Cornez BM; Jacobs JM; Miljoen HP; Vandendriessche TR; Claeys MJ; Bosmans JM; Vrints CJ
    Can J Cardiol; 2013 Sep; 29(9):1090-6. PubMed ID: 23422360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of PRO-kinetic metal alloy stent in hospitalized patients with acute ST-elevation myocardial infarction (The PROMETHEUS Study).
    Lim SY; Park HW; Chung WY; Kim SY; Kim KS; Bae JW; Youn TJ;
    J Invasive Cardiol; 2012 Jun; 24(6):270-3. PubMed ID: 22684380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do ultrathin strut bare-metal stents with passive coating improve efficacy in large coronary arteries? Insights from the randomized, multicenter BASKET-PROVE trials.
    Hansen KW; Jeger R; Sørensen R; Kaiser C; Pfisterer M; Biering-Sørensen T; Bjerking LH; Galatius S
    BMC Cardiovasc Disord; 2019 Oct; 19(1):226. PubMed ID: 31619181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective, multi-center evaluation of a silicon carbide coated cobalt chromium bare metal stent for percutaneous coronary interventions: two-year results of the ENERGY Registry.
    Erbel R; Eggebrecht H; Roguin A; Schroeder E; Philipp S; Heitzer T; Schwacke H; Ayzenberg O; Serra A; Delarche N; Luchner A; Slagboom T;
    Cardiovasc Revasc Med; 2014; 15(8):381-7. PubMed ID: 25456414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcome of thin-strut cobalt-chromium stents in the drug-eluting stent era: results of the COBALT (comparison of bare-metal stents in all-comers' lesion treatment) registry.
    Abdel-Wahab M; Toelg R; Kassner G; Klatt L; Sherif MA; Geist V; Richardt G
    J Interv Cardiol; 2011 Dec; 24(6):496-504. PubMed ID: 21981403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical investigation into the observation that silicon carbide coating on cobalt chromium stents leads to early differentiating functional endothelial layer, increased safety and DES-like recurrent stenosis rates: results of the PRO-Heal Registry (PRO-Kinetic enhancing rapid in-stent endothelialisation).
    Dahm JB; Willems T; Wolpers HG; Nordbeck H; Becker J; Ruppert J
    EuroIntervention; 2009 Jan; 4(4):502-8. PubMed ID: 19284073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
    Stone GW; Lansky AJ; Pocock SJ; Gersh BJ; Dangas G; Wong SC; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Ochala A; Kellock A; Parise H; Mehran R;
    N Engl J Med; 2009 May; 360(19):1946-59. PubMed ID: 19420364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of the cobalt chromium PRO-Kinetik coronary stent system: results of the MULTIBENE study.
    Vermeersch P; Appelman Y; Horstkotte D; Richardt G; Boland J; Lalmand J; Coussement P; Castadot M; Janssens L; Agostoni P; Buysschaert I; Suttorp MJ
    Cardiovasc Revasc Med; 2012; 13(6):316-20. PubMed ID: 23164477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
    Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease.
    Lansky AJ; Costa RA; Mooney M; Midei MG; Lui HK; Strickland W; Mehran R; Leon MB; Russell ME; Ellis SG; Stone GW;
    J Am Coll Cardiol; 2005 Apr; 45(8):1180-5. PubMed ID: 15837246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stents.
    Novack V; Nguyen MC; Rooney M; Chacko R; Novack L; Pencina M; Apruzzese P; Mauri L; Cohen SA; Moses J; Leon MB; Cutlip DE
    Am J Cardiol; 2010 Sep; 106(6):774-9. PubMed ID: 20816116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial.
    Moses JW; Mehran R; Nikolsky E; Lasala JM; Corey W; Albin G; Hirsch C; Leon MB; Russell ME; Ellis SG; Stone GW
    J Am Coll Cardiol; 2005 Apr; 45(8):1165-71. PubMed ID: 15837244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
    Wöhrle J; Werner GS
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infrapopliteal stenting with silicon carbide-coated stents in critical limb ischemia: a 12 month follow-up study.
    Atar E; Avrahami R; Koganovich Y; Litvin S; Knizhnik M; Belenky A
    Isr Med Assoc J; 2009 Oct; 11(10):611-4. PubMed ID: 20077948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry).
    Yan BP; Duffy SJ; Clark DJ; Lefkovits J; Warren R; Gurvitch R; Lew R; Sebastian M; Brennan A; Andrianopoulos N; Reid CM; Ajani AE;
    Am J Cardiol; 2008 Jun; 101(12):1716-22. PubMed ID: 18549846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Everolimus-eluting versus paclitaxel-eluting stents for treatment of bare metal stent restenosis.
    Almalla M; Schröder JW; Pross V; Stegemann E; Marx N; Hoffmann R
    Am J Cardiol; 2011 Aug; 108(4):518-22. PubMed ID: 21624553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.